1. Home
  2. ASNS vs GTBP Comparison

ASNS vs GTBP Comparison

Compare ASNS & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • GTBP
  • Stock Information
  • Founded
  • ASNS 1998
  • GTBP 1965
  • Country
  • ASNS United States
  • GTBP United States
  • Employees
  • ASNS N/A
  • GTBP N/A
  • Industry
  • ASNS Telecommunications Equipment
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • GTBP Health Care
  • Exchange
  • ASNS Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • ASNS 6.2M
  • GTBP 5.5M
  • IPO Year
  • ASNS 2022
  • GTBP N/A
  • Fundamental
  • Price
  • ASNS $0.72
  • GTBP $2.23
  • Analyst Decision
  • ASNS Strong Buy
  • GTBP Strong Buy
  • Analyst Count
  • ASNS 1
  • GTBP 1
  • Target Price
  • ASNS $5.00
  • GTBP $11.00
  • AVG Volume (30 Days)
  • ASNS 81.3K
  • GTBP 17.4K
  • Earning Date
  • ASNS 05-13-2025
  • GTBP 05-15-2025
  • Dividend Yield
  • ASNS N/A
  • GTBP N/A
  • EPS Growth
  • ASNS N/A
  • GTBP N/A
  • EPS
  • ASNS N/A
  • GTBP N/A
  • Revenue
  • ASNS $7,755,000.00
  • GTBP N/A
  • Revenue This Year
  • ASNS $31.44
  • GTBP N/A
  • Revenue Next Year
  • ASNS $54.00
  • GTBP N/A
  • P/E Ratio
  • ASNS N/A
  • GTBP N/A
  • Revenue Growth
  • ASNS 72.95
  • GTBP N/A
  • 52 Week Low
  • ASNS $0.36
  • GTBP $1.72
  • 52 Week High
  • ASNS $4.60
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 46.08
  • GTBP 46.01
  • Support Level
  • ASNS $0.70
  • GTBP $2.30
  • Resistance Level
  • ASNS $0.81
  • GTBP $2.37
  • Average True Range (ATR)
  • ASNS 0.06
  • GTBP 0.15
  • MACD
  • ASNS 0.00
  • GTBP -0.01
  • Stochastic Oscillator
  • ASNS 30.23
  • GTBP 14.55

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: